ATE207959T1 - Hilfsvirus für die herstellung von rekombinanten virusvektoren - Google Patents
Hilfsvirus für die herstellung von rekombinanten virusvektorenInfo
- Publication number
- ATE207959T1 ATE207959T1 AT96927107T AT96927107T ATE207959T1 AT E207959 T1 ATE207959 T1 AT E207959T1 AT 96927107 T AT96927107 T AT 96927107T AT 96927107 T AT96927107 T AT 96927107T AT E207959 T1 ATE207959 T1 AT E207959T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- production
- auxiliary
- vectors
- recombinase
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title 1
- 102000018120 Recombinases Human genes 0.000 abstract 2
- 108010091086 Recombinases Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
- 238000005215 recombination Methods 0.000 abstract 1
- 239000013603 viral vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
- C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9509289A FR2737501B1 (fr) | 1995-07-31 | 1995-07-31 | Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants |
| PCT/FR1996/001200 WO1997005255A2 (fr) | 1995-07-31 | 1996-07-30 | Virus auxiliaires pour la preparation de vecteurs viraux recombinants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE207959T1 true ATE207959T1 (de) | 2001-11-15 |
Family
ID=9481555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96927107T ATE207959T1 (de) | 1995-07-31 | 1996-07-30 | Hilfsvirus für die herstellung von rekombinanten virusvektoren |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6066478A (de) |
| EP (2) | EP0842279B1 (de) |
| JP (1) | JP3416143B2 (de) |
| AT (1) | ATE207959T1 (de) |
| AU (1) | AU715487B2 (de) |
| CA (1) | CA2225551A1 (de) |
| DE (1) | DE69616559T2 (de) |
| DK (1) | DK0842279T3 (de) |
| ES (1) | ES2164910T3 (de) |
| FR (1) | FR2737501B1 (de) |
| PT (1) | PT842279E (de) |
| WO (1) | WO1997005255A2 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020136708A1 (en) | 1993-06-24 | 2002-09-26 | Graham Frank L. | System for production of helper dependent adenovirus vectors based on use of endonucleases |
| US7045347B2 (en) | 1993-06-24 | 2006-05-16 | Advec, Inc. | Helper dependent adenovirus vectors based on integrase family site-specific recombinases |
| US20020146392A1 (en) * | 1993-06-24 | 2002-10-10 | Frank L. Graham | Helper dependent adenovirus vectors based on site-specific recombinases |
| JP4216350B2 (ja) * | 1994-09-19 | 2009-01-28 | 大日本住友製薬株式会社 | 動物細胞感染用の組換えｄｎａウイルスベクター |
| AU2004201152B2 (en) * | 1995-06-07 | 2007-03-08 | Advec, Inc. | Helper Dependent Adenovirus Vectors Based on Site-specific Recombinases |
| US6783980B2 (en) | 1995-06-15 | 2004-08-31 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| IL160406A0 (en) | 1995-06-15 | 2004-07-25 | Crucell Holland Bv | A cell harbouring nucleic acid encoding adenoritus e1a and e1b gene products |
| US6265212B1 (en) | 1995-06-15 | 2001-07-24 | Introgene B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| JP2002538758A (ja) * | 1998-02-17 | 2002-11-19 | ジェンザイム・コーポレイション | 偽アデノウイルスベクターの製造方法 |
| AUPP249298A0 (en) * | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| CN101818145A (zh) * | 1998-03-20 | 2010-09-01 | 联邦科学和工业研究组织 | 控制基因表达 |
| US8598332B1 (en) * | 1998-04-08 | 2013-12-03 | Bayer Cropscience N.V. | Methods and means for obtaining modified phenotypes |
| US20040214330A1 (en) * | 1999-04-07 | 2004-10-28 | Waterhouse Peter Michael | Methods and means for obtaining modified phenotypes |
| US6670188B1 (en) | 1998-04-24 | 2003-12-30 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
| PT1131087E (pt) * | 1998-11-13 | 2004-12-31 | Curis Inc | Metodos de alivio de sintomas de cancro |
| US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
| CA2442144A1 (en) * | 2001-03-26 | 2002-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | A helper dependent adenoviral vector system and methods for using the same |
| DE10159167A1 (de) * | 2001-12-03 | 2003-10-02 | Guenter Cichon | Expressionssystem |
| CA2483915A1 (en) * | 2002-05-02 | 2003-11-13 | University Of Rochester | Vectors having both isoforms of b-hexosaminidase |
| US20050101961A1 (en) * | 2003-11-12 | 2005-05-12 | Huebner Randall J. | Bone screws |
| EP1540004A4 (de) * | 2002-07-31 | 2007-10-03 | Nucleonics Inc | Doppelstrang-rna-strukturen und -konstrukte sowie verfahren zur erzeugung und verwendung davon |
| US20040203133A1 (en) * | 2003-01-07 | 2004-10-14 | Anja Ehrhardt | Helper dependent adenoviral vector system and methods for using the same |
| US7686839B2 (en) * | 2005-01-26 | 2010-03-30 | Lumitex, Inc. | Phototherapy treatment devices for applying area lighting to a wound |
| ES2337973B8 (es) * | 2008-05-16 | 2011-07-21 | Proyecto De Biomedicina Cima, S.L. | Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad. |
| CN103237890A (zh) * | 2010-06-02 | 2013-08-07 | 巴克斯特保健股份有限公司 | 用于产生rna 病毒的方法和辅助病毒 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0300422B1 (de) * | 1987-07-21 | 1992-12-02 | The Du Pont Merck Pharmaceutical Company | Verfahren für die Herstellung von in tierischen Zellen stabilen und lebensfähigen rekombinanten viralen Vektoren |
| US5173414A (en) * | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
| US5919676A (en) * | 1993-06-24 | 1999-07-06 | Advec, Inc. | Adenoviral vector system comprising Cre-loxP recombination |
| SK282843B6 (sk) | 1993-07-13 | 2002-12-03 | Rhone-Poulenc Rorer S. A. | Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom |
| FR2707664B1 (fr) * | 1993-07-13 | 1995-09-29 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
| JP3770333B2 (ja) * | 1995-03-15 | 2006-04-26 | 大日本住友製薬株式会社 | 組換えｄｎａウイルスおよびその製造方法 |
-
1995
- 1995-07-31 FR FR9509289A patent/FR2737501B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-30 US US09/011,257 patent/US6066478A/en not_active Expired - Fee Related
- 1996-07-30 AU AU67044/96A patent/AU715487B2/en not_active Ceased
- 1996-07-30 CA CA002225551A patent/CA2225551A1/fr not_active Abandoned
- 1996-07-30 DE DE69616559T patent/DE69616559T2/de not_active Expired - Fee Related
- 1996-07-30 WO PCT/FR1996/001200 patent/WO1997005255A2/fr not_active Ceased
- 1996-07-30 DK DK96927107T patent/DK0842279T3/da active
- 1996-07-30 ES ES96927107T patent/ES2164910T3/es not_active Expired - Lifetime
- 1996-07-30 AT AT96927107T patent/ATE207959T1/de not_active IP Right Cessation
- 1996-07-30 JP JP50729197A patent/JP3416143B2/ja not_active Expired - Fee Related
- 1996-07-30 PT PT96927107T patent/PT842279E/pt unknown
- 1996-07-30 EP EP96927107A patent/EP0842279B1/de not_active Expired - Lifetime
- 1996-07-30 EP EP01108475A patent/EP1132478A3/de not_active Withdrawn
-
2000
- 2000-05-02 US US09/563,239 patent/US6350575B1/en not_active Expired - Fee Related
-
2001
- 2001-08-03 US US09/920,932 patent/US20020072120A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6066478A (en) | 2000-05-23 |
| WO1997005255A2 (fr) | 1997-02-13 |
| DE69616559T2 (de) | 2002-06-27 |
| AU6704496A (en) | 1997-02-26 |
| FR2737501B1 (fr) | 1997-10-24 |
| WO1997005255A3 (fr) | 1997-03-06 |
| FR2737501A1 (fr) | 1997-02-07 |
| PT842279E (pt) | 2002-04-29 |
| DE69616559D1 (de) | 2001-12-06 |
| ES2164910T3 (es) | 2002-03-01 |
| EP0842279B1 (de) | 2001-10-31 |
| DK0842279T3 (da) | 2002-02-25 |
| CA2225551A1 (fr) | 1997-02-13 |
| EP1132478A2 (de) | 2001-09-12 |
| US20020072120A1 (en) | 2002-06-13 |
| EP0842279A2 (de) | 1998-05-20 |
| JP3416143B2 (ja) | 2003-06-16 |
| EP1132478A3 (de) | 2002-09-04 |
| US6350575B1 (en) | 2002-02-26 |
| JPH11510049A (ja) | 1999-09-07 |
| AU715487B2 (en) | 2000-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE207959T1 (de) | Hilfsvirus für die herstellung von rekombinanten virusvektoren | |
| GB9803351D0 (en) | Anti-viral vectors | |
| CA2157063A1 (en) | Recombinant dna viral vector for transfecting animal cells | |
| WO1995006743A3 (en) | Methods and compositions for the large scale production of recombinant adeno-associated virus | |
| DK0749444T3 (da) | Human/dyre-faktor VIII-hybrid | |
| EP0260148A3 (de) | Rekombinantes Expressionsverfahren, Vektor und tranformierte Zellen | |
| IL145288A0 (en) | Novel cytokin zalpha11 ligand | |
| AU9338598A (en) | Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences | |
| DE59911900D1 (de) | Retrovirale, mit LCMV-Glykoprotein pseudotypisierte Hybrid-Vektoren | |
| HU904957D0 (en) | Parenchymal liver call growth factor, the gene coding this and process for producing transformants creating this factor | |
| AU3802595A (en) | Tripeptidyl aminopeptidase | |
| KR960001819B1 (en) | Viral vector coding for a glycoprotein of the virus responsible | |
| ATE185604T1 (de) | Gentechnische herstellung von faktor xiiia | |
| DK0835137T3 (da) | Indkapslede celler, som danner viruspartikler | |
| FI970892A0 (fi) | Ilmentymiseltään kohdennetut retrovirusvektorit, jotka eivät ole itsestään inaktivoivia | |
| CA2263790A1 (en) | Method for immortalizing cells | |
| AU582288B2 (en) | Vector and method for achieving high level expression in eukaryotic cells | |
| EP0776972A4 (de) | FÜR DAS IgG-Fc-BINDENDE PROTEIN KODIERENDES GEN | |
| ATE173762T1 (de) | Klonierung der n-methylhydantoinase | |
| NO175872C (no) | Plasmidvektor, fremgangsmåte for fremstilling av peptider og myelomcelle | |
| DE3888386D1 (de) | Verfahren zur Herstellung von Proteinen. | |
| DE69637429D1 (de) | Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert | |
| KR900009979A (ko) | 일본 뇌염 비루스 비구조 단백질의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |